Improved chest CT diagnostics and contrast medium administration.
Should ultra low dose CT replace the chest x-ray as the first choice of referral in lung diagnostics?
Long-term clinical respiratory outcomes in patients hospitalized with COVID-19 infection. PROLUN and NOR-SOLIDARITY sub studies
Optimisation of CT thorax using hyperdrive and AI based reconstruction, phantom studies and clinical study.
Differentiation betweenintrapulmonary lymph nodes and early stage lung metastases from colorectal cancer based on chest CT
Radiologic characterization of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency. Cross-sectional studies on the unselected patient cohorts.
In collaboration with the Department of Rheumatology and Department of Pulmonology several ongoing inter-disciplinary, cross-sectional studies on interstitial lung disease in idiopathic disorders and patient cohorts with connective tissue diseases and primary vasculitidis
Henning MK, Aaløkken TM, Martinsen AC, Johansen S(2023) The impact of body compositions on contrast medium enhancement in chest CT: a randomised controlled trial BJR Open, 5(1), 20230054 DOI 10.1259/bjro.20230054, PubMed 37942494
Lerum TV, Meltzer C, Rodriguez JR, Aaløkken TM, Brønstad E, Aarli BB, Aarberg-Lund KM, Durheim MT, Ashraf H, Einvik G, Skjønsberg OH, Stavem K(2023) A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19 ERJ Open Res, 9(2) DOI 10.1183/23120541.00575-2022, PubMed 36915802
Murphy SL, Halvorsen B, Holter JC, Huse C, Tveita A, Trøseid M, Hoel H, Kildal AB, Holten AR, Lerum TV, Skjønsberg OH, Michelsen AE, Aaløkken TM, NOR-SOLIDARITY Consortium, The Norwegian SARS-CoV-2 study group investigators, Tonby K, Lind A, Dudman S, Granerud BK, Heggelund L, Bøe S, Dyrholt-Riise AM, Aukrust P, Barratt-Due A, Ueland T, Dahl TB(2023) Circulating markers of extracellular matrix remodelling in severe COVID-19 patients J Intern Med, 294(6), 784-797 DOI 10.1111/joim.13725, PubMed 37718572
Get in touch
Trond Mogens Aaløkken, Group leader, Consultant; MD, PhD Department of Radiology, Rikshospitalet, taalokke@ous-hf.no Mob. 95906881